As of 2026-09-29, the Relative Valuation of MEI Pharma Inc (MEIP) is 11.78 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.07 USD, the upside of MEI Pharma Inc based on Relative Valuation is 283.6%.
The range of the Relative Valuation is 9.21 - 13.20 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 20.3x - 29.0x | 25.9x |
| Fair Price | 9.21 - 13.20 | 11.78 |
| Upside | 200.1% - 329.9% | 283.6% |
| Date | P/E |